Engineering Breast Cancer Microenvironments and 3D Bioprinting
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The extracellular matrix (ECM) is a critical cue to direct tumorigenesis and metastasis. Although two-dimensional (2D) culture models have been widely employed to understand breast cancer microenvironments over the past several decades, the 2D models still exhibit limited success. Overwhelming evidence supports that three dimensional (3D), physiologically relevant culture models are required to better understand cancer progression and develop more effective treatment. Such platforms should include cancer-specific architectures, relevant physicochemical signals, stromal-cancer cell interactions, immune components, vascular components, and cell-ECM interactions found in patient tumors. This review briefly summarizes how cancer microenvironments (stromal component, cell-ECM interactions, and molecular modulators) are defined and what emerging technologies (perfusable scaffold, tumor stiffness, supporting cells within tumors and complex patterning) can be utilized to better mimic native-like breast cancer microenvironments. Furthermore, this review emphasizes biophysical properties that differ between primary tumor ECM and tissue sites of metastatic lesions with a focus on matrix modulation of cancer stem cells, providing a rationale for investigation of underexplored ECM proteins that could alter patient prognosis. To engineer breast cancer microenvironments, we categorized technologies into two groups: (1) biochemical factors modulating breast cancer cell-ECM interactions and (2) 3D bioprinting methods and its applications to model breast cancer microenvironments. Biochemical factors include matrix-associated proteins, soluble factors, ECMs, and synthetic biomaterials. For the application of 3D bioprinting, we discuss the transition of 2D patterning to 3D scaffolding with various bioprinting technologies to implement biophysical cues to model breast cancer microenvironments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Cell Movement Is Guided by the Rigidity of the Substrate
Lo, C.-M., Wang, H.-B., Dembo, M., & Wang, Y.-L. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76279-5 · Cited by 3,289
The present and future role of microfluidics in biomedical research
Sackmann, E. K., Fulton, A. L., & Beebe, D. J. (2014) · Nature · doi:10.1038/nature13118 · Cited by 2,995
Hydrogels with tunable stress relaxation regulate stem cell fate and activity
Chaudhuri, O., Gu, L., Klumpers, D., Darnell, M., Bencherif, S. A., Weaver, J. C., Huebsch, N., Lee, H.-P., Lippens, E., Duda, G. N., et al. (2016) · Nature Materials · doi:10.1038/nmat4489 · Cited by 2,443
25th Anniversary Article: Engineering Hydrogels for Biofabrication
Malda, J., Visser, J., Melchels, F. P., Jüngst, T., Hennink, W. E., Dhert, W. J. A., Groll, J., & Hutmacher, D. W. (2013) · Advanced Materials · doi:10.1002/adma.201302042 · Cited by 1,901
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847 · cited 5×
“TH2 cells secrete IL-4, IL-6, and IL-13; TH1 cells secrete IFN-γ; and TH17 cells secrete IL-17 (Borthwick et al., 2013; Mora-Solano and Collier, 2014; De Palma et al., 2017).”
BackgroundInfluentialHinton, T. J., Jallerat, Q., Palchesko, R. N., Park, J. H., Grodzicki, M. S., Shue, H.-J., Ramadan, M. H., Hudson, A. R., & Feinberg, A. W. (2015) · Science Advances · doi:10.1126/sciadv.1500758 · Cited by 1,805
Cox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569
Extracellular Matrix Assembly: A Multiscale Deconstruction
Mouw, J. K., Ou, G., & Weaver, V. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3902 · Cited by 1,534 · cited 1×
“ECM is broadly divided into two groups: the interstitial matrix, formed of fibrillar collagens, and the basement membrane, composed of non-fibrillar proteins and proteoglycans (Mouw et al., 2014).”
BackgroundNaba, A., Clauser, K. R., Hoersch, S., Liu, H., Carr, S. A., & Hynes, R. O. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014647 · Cited by 1,354
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872 · cited 1×
“Utilizing the precise patterning and control of microfluidics, 3D vascular networks can be constructed to examine how cancer cells extravasate (Chen et al., 2013; Jeon et al., 2015) and intravasate (Zervantonakis et al., 2012) during metastasis.”
BackgroundComparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
IMAMURA, Y., MUKOHARA, T., SHIMONO, Y., FUNAKOSHI, Y., CHAYAHARA, N., TOYODA, M., KIYOTA, N., TAKAO, S., KONO, S., NAKATSURA, T., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3767 · Cited by 845 · cited 1×
“…drug efficacy between 2D and 3D cultures is imperative as chemotherapies (paclitaxel, doxorubicin, and 5- fluorouracil) are less effective in drug sensitivity studies by simply changing the dimensionality of the platform (2D to 3D) or from in vitro to in vivo experiment (Imamura et al., 2015).”
BackgroundChaudhuri, O., Koshy, S. T., Branco da Cunha, C., Shin, J.-W., Verbeke, C. S., Allison, K. H., & Mooney, D. J. (2014) · Nature Materials · doi:10.1038/nmat4009 · Cited by 820
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774
In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform
Katt, M. E., Placone, A. L., Wong, A. D., Xu, Z. S., & Searson, P. C. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00012 · Cited by 754 · cited 1×
“In a recent review, the authors produce a comprehensive view on in vitro tumor models providing advantages and disadvantages for selecting the right platform (Katt et al., 2016).”
BackgroundTumor-associated stromal cells as key contributors to the tumor microenvironment
Bussard, K. M., Mutkus, L., Stumpf, K., Gomez-Manzano, C., & Marini, F. C. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0740-2 · Cited by 746 · cited 1×
“These endothelial cells also secrete TNFα which helps stimulate cancer cell secretion of CXCL1/2 resulting in increases in cancer cell survival (Bussard et al., 2016; De Palma et al., 2017).”
BackgroundHuman 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723 · cited 1×
“Utilizing the precise patterning and control of microfluidics, 3D vascular networks can be constructed to examine how cancer cells extravasate (Chen et al., 2013; Jeon et al., 2015) and intravasate (Zervantonakis et al., 2012) during metastasis.”
BackgroundStromal cells in tumor microenvironment and breast cancer
Mao, Y., Keller, E. T., Garfield, D. H., Shen, K., & Wang, J. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9415-3 · Cited by 671 · cited 5×
“Cancer-associated inflammatory cells produce cytokines, chemokines, MMPs, and other factors to mediate carcinogenesis andmetastasis in lungs (Mao et al., 2013; Shi et al., 2015).”
BackgroundInfluentialNeutrophils in the tumor microenvironment
Powell, D. R., & Huttenlocher, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2015.11.008 · Cited by 578
3D cell culture systems modeling tumor growth determinants in cancer target discovery
Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M., & Krek, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.001 · Cited by 478
Matrigel: From discovery and ECM mimicry to assays and models for cancer research
Benton, G., Arnaoutova, I., George, J., Kleinman, H. K., & Koblinski, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.005 · Cited by 477 · cited 2×
“For example, MatrigelTM lacks species specificity, displays batch-to-batch variability in biochemical and biophysical properties (Benton et al., 2014), and cannot be easily tuned for systematic studies (Asghar et al., 2015; Leggett et al., 2017); the mechanical resilience of collagen gel (primarily…”
BackgroundHinderer, S., Layland, S. L., & Schenke-Layland, K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.019 · Cited by 469 · cited 1×
“Due to the need for high electrical fields and harsh solvents, it is a challenging method to maintain native protein function (Hinderer et al., 2016).”
BackgroundBiomaterials and emerging anticancer therapeutics: engineering the microenvironment
Gu, L., & Mooney, D. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.3 · Cited by 407 · cited 6×
“Synthetic materials include polyacrylamide (PA), polydimethylsiloxane (PDMS), poly(ethylene glycol) (PEG), and poly(lactide-co-glycolic acid) (PLGA) provide more precise control of mechanical properties but lack cell adhesion and cytocompatibility (Gu and Mooney, 2016).”
BackgroundInfluentialCytokine mediated tissue fibrosis
Borthwick, L. A., Wynn, T. A., & Fisher, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.014 · Cited by 375
Bioprinting for cancer research
Knowlton, S., Onal, S., Yu, C. H., Zhao, J. J., & Tasoglu, S. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.06.007 · Cited by 361
Xu, F., Celli, J., Rizvi, I., Moon, S., Hasan, T., & Demirci, U. (2011) · Biotechnology Journal · doi:10.1002/biot.201000340 · Cited by 337
Engineering cancer microenvironments for in vitro 3-D tumor models
Asghar, W., El Assal, R., Shafiee, H., Pitteri, S., Paulmurugan, R., & Demirci, U. (2015) · Materials Today · doi:10.1016/j.mattod.2015.05.002 · Cited by 316 · cited 2×
“…batch-to-batch variability in biochemical and biophysical properties (Benton et al., 2014), and cannot be easily tuned for systematic studies (Asghar et al., 2015; Leggett et al., 2017); the mechanical resilience of collagen gel (primarily with collagen type I) is limited in comparison to…”
MethodResultMechanisms of tumor cell extravasation in an in vitro microvascular network platform
Chen, M. B., Whisler, J. A., Jeon, J. S., & Kamm, R. D. (2013) · Integrative Biology · doi:10.1039/c3ib40149a · Cited by 308 · cited 1×
“Utilizing the precise patterning and control of microfluidics, 3D vascular networks can be constructed to examine how cancer cells extravasate (Chen et al., 2013; Jeon et al., 2015) and intravasate (Zervantonakis et al., 2012) during metastasis.”
BackgroundJeong, S.-Y., Lee, J.-H., Shin, Y., Chung, S., & Kuh, H.-J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159013 · Cited by 287 · cited 2×
“For instance, a microfluidics chamber is constructed to co-culture cancer cells and fibroblasts, demonstrating that the co-culture system enhances proliferation, paclitaxel resistance, and fibronectin expression relative to a mono-culture system (Jeong et al., 2016).”
BackgroundThree-Dimensional In Vitro Co-Culture Model of Breast Tumor using Magnetic Levitation
Jaganathan, H., Gage, J., Leonard, F., Srinivasan, S., Souza, G. R., Dave, B., & Godin, B. (2014) · Scientific Reports · doi:10.1038/srep06468 · Cited by 231
Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment
Tsai, H.-F., Trubelja, A., Shen, A. Q., & Bao, G. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0137 · Cited by 214
Bioprinting towards physiologically relevant tissue models for pharmaceutics
Peng, W., Unutmaz, D., & Ozbolat, I. T. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.05.013 · Cited by 196
Microfluidic 3D models of cancer
Sung, K. E., & Beebe, D. J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.002 · Cited by 190 · cited 2×
“With such complex patterns, multiple cell types are able to communicate and influence each other (Sung and Beebe, 2014; Regier et al., 2016).”
BackgroundA versatile 3D tissue matrix scaffold system for tumor modeling and drug screening
Rijal, G., & Li, W. (2017) · Science Advances · doi:10.1126/sciadv.1700764 · Cited by 154 · cited 1×
“Additionally, drug resistance was decreased on TMS when compared to the other 3D scaffolds (Rijal and Li, 2017).”
BackgroundHydrogels to model 3D in vitro microenvironment of tumor vascularization
Song, H.-H. G., Park, K. M., & Gerecht, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.002 · Cited by 153
3D Matrices for Anti-Cancer Drug Testing and Development
Gurski, L. A., Petrelli, N. J., Jia, X., & Farach-Carson, M. C. (2010) · Oncology Issues · doi:10.1080/10463356.2010.11883480 · Cited by 130 · cited 1×
“By simply taking 2D to 3D cell culture via gels of collagen type I or MatrigelTM, noticeable changes are observed in cell morphology, growth rates, metabolism, and drug sensitivities (Gurski et al., 2017).”
MethodYue, X., Nguyen, T. D., Zellmer, V., Zhang, S., & Zorlutuna, P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.001 · Cited by 97
Gill, B. J., & West, J. L. (2014) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2013.09.029 · Cited by 86
Ma, L., Barker, J., Zhou, C., Li, W., Zhang, J., Lin, B., Foltz, G., Küblbeck, J., & Honkakoski, P. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.054 · Cited by 83
Laser direct-write onto live tissues: a novel model for studying cancer cell migration
Burks, H. E., Phamduy, T. B., Azimi, M. S., Saksena, J., Burow, M. E., Collins‐Burow, B. M., Chrisey, D. B., & Murfee, W. L. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25363 · Cited by 48 · cited 1×
“After 5 days of culture, mesentery sections where MDA-MB-231 were printed showed increased number of new capillary sprouts in comparison to mesentery sections without any printing (Phamduy et al., 2015; Burks et al., 2016).”
BackgroundSelf-citation
Cited by
Emerging roles of ECM remodeling processes in cancer
Mohan, V., Das, A., & Sagi, I. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.004 · Cited by 334
3D bioprinting for reconstituting the cancer microenvironment
Datta, P., Dey, M., Ataie, Z., Unutmaz, D., & Ozbolat, I. T. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-0121-2 · Cited by 304
Modeling neoplastic disease with spheroids and organoids
Zanoni, M., Cortesi, M., Zamagni, A., Arienti, C., Pignatta, S., & Tesei, A. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00931-0 · Cited by 261
Breast cancer models: Engineering the tumor microenvironment
Bahcecioglu, G., Basara, G., Ellis, B. W., Ren, X., & Zorlutuna, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.006 · Cited by 213
Comparison of Drug Inhibitory Effects ($$\hbox {IC}_{50}$$) in Monolayer and Spheroid Cultures
Berrouet, C., Dorilas, N., Rejniak, K. A., & Tuncer, N. (2020) · Bulletin of Mathematical Biology · doi:10.1007/s11538-020-00746-7 · Cited by 133
Metadata
- Authors
- Belgodere, J. A., King, C. T., Bursavich, J. B., Burow, M. E., Martin, E. C., & Jung, J. P.
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2018-05-24
- Volume
- 6
- Pages
- 66-66
- ISSN
- 2296-4185 (ISSN-L)
- OpenAlex
- W2801095534
- Cited by
- 109
- References
- 41
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.